Document Specialty Meds in the EHR, Even if You're NOT the Prescriber
March 2016
You'll hear more about specialty meds...Repatha (evolocumab), Harvoni (ledipasvir/sofosbuvir), Gleevec (imatinib), etc.
Specialty meds account for about half of new drugs approved in 2015...and these meds will make up over half of drug spending by 2017.
What makes specialty meds "special"? They're generally high-cost and "high-touch"...such as requiring specific testing before starting the med, a detailed monitoring plan, or unique storage.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote